BDBM50083775 3-[(5-{2-[3-(1H-Imidazol-2-yl)-ureido]-ethyl}-4,5-dihydro-isoxazole-3-carbonyl)-amino]-2-(2,4,6-trimethyl-benzenesulfonylamino)-propionic acid::CHEMBL128784

SMILES Cc1cc(C)c(c(C)c1)S(=O)(=O)N[C@@H](CNC(=O)C1=NOC(CCNC(=O)Nc2ncc[nH]2)C1)C(O)=O

InChI Key InChIKey=VGELBWOMJQZBAK-LWKPJOBUSA-N

Data  3 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 50083775   

TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083775(3-[(5-{2-[3-(1H-Imidazol-2-yl)-ureido]-ethyl}-4,5-...)
Affinity DataIC50:  34nMAssay Description:Inhibition of vitronectin receptor (alpha V beta 3), expressed on human 293 cells, binding to immobilized fibrinogenMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083775(3-[(5-{2-[3-(1H-Imidazol-2-yl)-ureido]-ethyl}-4,5-...)
Affinity DataIC50:  1.20E+5nMAssay Description:Inhibition of platelet aggregation in human platelet rich plasma (PRP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083775(3-[(5-{2-[3-(1H-Imidazol-2-yl)-ureido]-ethyl}-4,5-...)
Affinity DataIC50:  3.20E+4nMAssay Description:Inhibition of platelet aggregation in human gel-purified platelets containing fibrinogen (GPP+Fg).More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed